Pharma Mar SA (PHMMF)
94.60
0.00 (0.00%)
USD |
OTCM |
Oct 07, 16:00
Pharma Mar Max Drawdown (5Y) : 98.44% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 98.44% |
| August 31, 2026 | 98.44% |
| July 31, 2026 | 98.44% |
| June 30, 2026 | 98.44% |
| May 31, 2026 | 98.44% |
| April 30, 2026 | 98.44% |
| March 31, 2026 | 98.44% |
| February 28, 2026 | 98.44% |
| January 31, 2026 | 98.44% |
| December 31, 2025 | 98.44% |
| November 30, 2025 | 98.44% |
| October 31, 2025 | 98.44% |
| September 30, 2025 | 98.44% |
| August 31, 2025 | 98.44% |
| July 31, 2025 | 98.44% |
| June 30, 2025 | 98.44% |
| May 31, 2025 | 98.44% |
| April 30, 2025 | 98.44% |
| March 31, 2025 | 98.44% |
| February 28, 2025 | 98.44% |
| January 31, 2025 | 98.44% |
| December 31, 2024 | 98.44% |
| November 30, 2024 | 98.44% |
| October 31, 2024 | 98.44% |
| September 30, 2024 | 98.44% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.44% |
| July 31, 2024 | 98.44% |
| June 30, 2024 | 98.44% |
| May 31, 2024 | 98.44% |
| April 30, 2024 | 98.44% |
| March 31, 2024 | 98.30% |
| February 29, 2024 | 98.13% |
| January 31, 2024 | 98.13% |
| December 31, 2023 | 98.13% |
| November 30, 2023 | 98.13% |
| October 31, 2023 | 98.13% |
| September 30, 2023 | 98.06% |
| August 31, 2023 | 98.05% |
| July 31, 2023 | 98.05% |
| June 30, 2023 | 98.05% |
| May 31, 2023 | 98.05% |
| April 30, 2023 | 97.48% |
| March 31, 2023 | 97.27% |
| February 28, 2023 | 97.09% |
| January 31, 2023 | 97.09% |
| December 31, 2022 | 97.09% |
| November 30, 2022 | 97.09% |
| October 31, 2022 | 97.09% |
| September 30, 2022 | 97.09% |
| August 31, 2022 | 96.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Oryzon Genomics SA | 70.44% |
| Grifols SA | 77.82% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alkermes Plc | 68.08% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -9.183 |
| Beta (5Y) | 0.7605 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 51.38% |
| Historical Sharpe Ratio (5Y) | -0.0306 |
| Historical Sortino (5Y) | -0.0528 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.97% |